Trial Profile
Retrospective study investigating the efficacy of Entecavir/Tenofovir as de novo treatment and as treatment after lamivudine failure in Hepatitis B patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Leukaemia; Lymphoma; Multiple myeloma; Solid tumours
- Focus Therapeutic Use
- 22 Dec 2015 New trial record